Northeast Investment Management Moderna, Inc. Transaction History

Northeast Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $11,595 - $17,482	-99 Reduced 1.42%	6,893 $985,000
Q1 2022 May 04, 2022	SELL	$126.46 - $235.05 $141,635 - $263,256	-1,120 Reduced 13.81%	6,992 $1.2 Million
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $840,727 - $1.37 Million	-3,723 Reduced 31.46%	8,112 $2.06 Million
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $96,082 - $209,775	433 Added 3.8%	11,835 $4.56 Million
Q2 2021 Aug 05, 2021	BUY	$129.91 - $234.98 $84,441 - $152,737	650 Added 6.05%	11,402 $2.68 Million
Q4 2020 Feb 10, 2021	SELL	$65.74 - $169.86 $788 - $2,038	-12 Reduced 0.11%	10,752 $1.12 Million
Q3 2020 Nov 13, 2020	SELL	$54.34 - $94.85 $3,260 - $5,691	-60 Reduced 0.55%	10,764 $762,000
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $321,148 - $865,920	10,824 New	10,824 $695,000

940

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $13.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

Stay updated on Northeast Investment Management with notifications on news.